Eisai
4523.T
#2011
Rank
HK$60.34 B
Marketcap
HK$214.08
Share price
-0.25%
Change (1 day)
-44.97%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

Eisai (4523.T) - Total debt

Total debt on the balance sheet as of March 2024 : HK$8.18 Billion

According to Eisai's latest financial reports the company's total debt is HK$8.18 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Eisai - Total debt on balance sheet (from 2009 to 2024)

20102013201620192022$10B$20B$30B$40Bcompaniesmarketcap.com

Total debt by year

Year Total debt Change
2023-03-31HK$7.43 B22.09%
2022-03-31HK$6.08 B-3.94%
2021-03-31HK$6.33 B-1.84%
2020-03-31HK$6.45 B-34.29%
2019-03-31HK$9.82 B-23.16%
2018-03-31HK$12.78 B-13.85%
2017-03-31HK$14.83 B5.63%
2016-03-31HK$14.04 B-7.9%
2015-03-31HK$15.25 B-18.16%
2014-03-31HK$18.63 B-27.92%
2013-03-31HK$25.85 B-20.07%
2012-03-31HK$32.35 B-9.02%
2011-03-31HK$35.55 B4.52%
2010-03-31HK$34.02 B3.05%
2009-03-31HK$33.01 B2.37%
2008-03-31HK$32.24 B205864.42%
2007-03-31HK$15.65 M-42.46%
2006-03-31HK$27.21 M-55.17%
2005-03-31HK$60.7 M325.2%
2004-03-31HK$14.27 M517.23%
2003-03-31HK$2.31 M-99.4%
2002-03-31HK$0.38 B-21.55%
2001-03-31HK$0.48 B-64.33%
2000-03-31HK$1.36 B